HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 9 analysts with an average price target of $65.26. This is a potential upside of $6.79 (11.61%) from yesterday's end of day stock price of $58.47.

Halozyme Therapeutics's activity chart (see below) currently has 121 price targets and 131 ratings on display. The stock rating distribution of HALO is 95.16% BUY and 4.84% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.38% with an average time for these price targets to be met of 284 days.

Highest price target for HALO is $73, Lowest price target is $49, average price target is $65.26.

Most recent stock forecast was given by JASON BUTLER from JMP on 01-Nov-2024. First documented stock forecast 11-Jun-2014.

Currently out of the existing stock ratings of HALO, 59 are a BUY (95.16%), 3 are a HOLD (4.84%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$73

$15.85 (27.73%)

$71

4 days ago
(01-Nov-2024)

6/12 (50%)

$15.85 (27.73%)

312

Buy

$68

$10.85 (18.99%)

$65

4 days ago
(01-Nov-2024)

13/24 (54.17%)

$10.85 (18.99%)

190

Buy

$62

$4.85 (8.49%)

$58

29 days ago
(07-Oct-2024)

4/6 (66.67%)

$8.15 (15.13%)

254

Buy

$57

$-0.15 (-0.26%)

$52

1 months 17 days ago
(19-Sep-2024)

6/6 (100%)

$-2.5 (-4.20%)

118

Buy

$60

$2.85 (4.99%)

$60

2 months 28 days ago
(08-Aug-2024)

4/5 (80%)

$5.54 (10.17%)

109

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 284 days on average for the stock forecasts to be realized with a an average price target met ratio 84.38

Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?

VIKRAM PUROHIT

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Vikram Purohit works at MORGAN STANLEY and has 1 price targets and 1 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Geoffrey Porges with highest potential upside - $16.84

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with lowest potential downside - -$44.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?